Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$52.45
0.651.25%
À la fermeture: -
$52.45
0.000.00%
Après les heures de négociation: 4:11 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
EQT Corp a un objectif de cours consensus de $61.91, basé sur les évaluations des 24 analystes. Le plus élevé est de $80 attribué par B of A Securities le août 22, 2025, et le plus bas est de $40 attribué par BMO Capital le octobre 4, 2024. Les 3 dernières évaluations d'analystes ont été publiées par Wells Fargo, UBS et Scotiabank le octobre 23, 2025, octobre 17, 2025 et octobre 9, 2025. Avec un objectif de cours moyen de $67.67 entre Wells Fargo, UBS et Scotiabank, il y a une variation implicite de 29.01% upside pour EQT Corp à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Wells Fargo
UBS
Scotiabank
Barclays
RBC Capital
1calculé à partir des notes des analystes
Notes d'analystes pour EQT
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/23/2025 | 25.83% | Wells Fargo | $68 → $66 | Maintains | Overweight | |||
10/17/2025 | 27.74% | UBS | $65 → $67 | Maintains | Buy | |||
10/15/2025 | — | William Blair | — | Initiates | → Outperform | |||
10/09/2025 | 33.46% | Scotiabank | $68 → $70 | Maintains | Sector Perform | |||
10/07/2025 | 27.74% | Barclays | $68 → $67 | Maintains | Overweight | |||
10/07/2025 | 18.21% | RBC Capital | $60 → $62 | Maintains | Sector Perform | |||
10/02/2025 | 29.65% | Jefferies | $70 → $68 | Maintains | Buy | |||
09/30/2025 | 18.21% | JP Morgan | $64 → $62 | Maintains | Overweight | |||
08/22/2025 | 52.53% | B of A Securities | $63 → $80 | Maintains | Buy | |||
08/20/2025 | 23.93% | UBS | $64 → $65 | Maintains | Buy | |||
08/20/2025 | 22.02% | Melius Research | → $64 | Initiates | → Buy | |||
08/18/2025 | 8.67% | Roth Capital | $75 → $57 | Downgrade | Buy → Neutral | |||
08/13/2025 | 29.65% | Scotiabank | $66 → $68 | Maintains | Sector Perform | |||
07/25/2025 | -6.58% | Piper Sandler | $48 → $49 | Maintains | Neutral | |||
07/23/2025 | 42.99% | Roth Capital | $72 → $75 | Maintains | Buy | |||
07/23/2025 | 29.65% | Barclays | $65 → $68 | Maintains | Overweight | |||
07/11/2025 | 25.83% | Scotiabank | $62 → $66 | Maintains | Sector Perform | |||
07/08/2025 | 33.46% | Jefferies | $60 → $70 | Maintains | Buy | |||
07/08/2025 | 14.39% | RBC Capital | $55 → $60 | Maintains | Sector Perform | |||
07/08/2025 | 25.83% | Mizuho | → $66 | Reinstates | → Outperform | |||
07/07/2025 | 23.93% | Barclays | → $65 | Initiates | → Overweight | |||
06/24/2025 | 31.55% | Roth Capital | → $69 | Initiates | → Buy | |||
06/16/2025 | 20.11% | Wells Fargo | $59 → $63 | Maintains | Overweight | |||
05/22/2025 | 18.21% | Scotiabank | $57 → $62 | Maintains | Sector Perform | |||
05/13/2025 | -8.48% | Piper Sandler | $35 → $48 | Maintains | Neutral | |||
05/05/2025 | 22.02% | UBS | $54 → $64 | Upgrade | Neutral → Buy | |||
04/28/2025 | 20.11% | B of A Securities | $60 → $63 | Maintains | Buy | |||
04/24/2025 | 23.93% | Morgan Stanley | $62 → $65 | Maintains | Overweight | |||
04/22/2025 | -33.27% | Piper Sandler | $36 → $35 | Maintains | Neutral | |||
04/17/2025 | 2.96% | UBS | $55 → $54 | Maintains | Neutral | |||
04/15/2025 | 8.67% | Stephens & Co. | $59 → $57 | Maintains | Overweight | |||
04/11/2025 | 8.67% | Scotiabank | $54 → $57 | Maintains | Sector Perform | |||
04/08/2025 | 2.96% | TD Cowen | $54 → $54 | Upgrade | Hold → Buy | |||
04/07/2025 | 4.86% | UBS | $58 → $55 | Maintains | Neutral | |||
04/01/2025 | 14.39% | Mizuho | $57 → $60 | Maintains | Outperform | |||
03/27/2025 | 27.74% | Morgan Stanley | $63 → $67 | Maintains | Overweight | |||
03/19/2025 | 10.58% | Wells Fargo | $53 → $58 | Maintains | Overweight | |||
03/18/2025 | 12.49% | Stephens & Co. | $41 → $59 | Upgrade | Equal-Weight → Overweight | |||
03/17/2025 | 14.39% | Citigroup | $51 → $60 | Maintains | Buy | |||
03/13/2025 | 14.39% | JP Morgan | $58 → $60 | Maintains | Overweight | |||
03/06/2025 | -31.36% | Piper Sandler | $35 → $36 | Maintains | Neutral | |||
02/25/2025 | 10.58% | UBS | $54 → $58 | Maintains | Neutral | |||
02/20/2025 | 10.58% | JP Morgan | $53 → $58 | Maintains | Overweight | |||
02/13/2025 | 2.96% | UBS | $49 → $54 | Maintains | Neutral | |||
02/12/2025 | 25.83% | Goldman Sachs | $59 → $66 | Maintains | Buy | |||
01/29/2025 | -33.27% | Piper Sandler | $34 → $35 | Maintains | Neutral | |||
01/17/2025 | 2.96% | Scotiabank | $55 → $54 | Downgrade | Sector Outperform → Sector Perform | |||
01/15/2025 | 39.18% | Bernstein | $73 → $73 | Upgrade | Market Perform → Outperform | |||
01/13/2025 | 6.77% | Truist Securities | $41 → $56 | Maintains | Hold | |||
01/08/2025 | 1.05% | Wells Fargo | $52 → $53 | Maintains | Overweight | |||
01/06/2025 | -6.58% | RBC Capital | $49 → $49 | Reiterates | Sector Perform → Sector Perform | |||
01/03/2025 | 4.86% | Jefferies | $45 → $55 | Maintains | Buy | |||
01/03/2025 | 1.05% | JP Morgan | $50 → $53 | Maintains | Overweight | |||
12/16/2024 | 8.67% | Mizuho | $48 → $57 | Upgrade | Neutral → Outperform | |||
12/06/2024 | -2.76% | Citigroup | $44 → $51 | Maintains | Buy | |||
12/06/2024 | -4.67% | Bernstein | → $50 | Initiates | → Market Perform | |||
12/03/2024 | -6.58% | RBC Capital | → $49 | Reinstates | → Sector Perform | |||
11/26/2024 | -8.48% | Mizuho | $45 → $48 | Maintains | Neutral | |||
11/26/2024 | -21.83% | Truist Securities | $32 → $41 | Maintains | Hold | |||
11/25/2024 | -0.86% | Wells Fargo | $42 → $52 | Maintains | Overweight | |||
11/25/2024 | 6.77% | Morgan Stanley | $45 → $56 | Maintains | Overweight | |||
11/05/2024 | -14.2% | Mizuho | $41 → $45 | Maintains | Neutral | |||
11/04/2024 | -35.18% | Piper Sandler | $32 → $34 | Maintains | Neutral | |||
11/04/2024 | -19.92% | UBS | $40 → $42 | Maintains | Neutral | |||
10/30/2024 | -27.55% | Stephens & Co. | $37 → $38 | Maintains | Equal-Weight | |||
10/04/2024 | -23.74% | BMO Capital | $39 → $40 | Maintains | Outperform | |||
10/04/2024 | -21.83% | Mizuho | $43 → $41 | Maintains | Neutral | |||
10/03/2024 | -16.11% | Citigroup | $37 → $44 | Upgrade | Neutral → Buy | |||
09/26/2024 | -25.64% | JP Morgan | $37 → $39 | Maintains | Overweight | |||
09/18/2024 | -31.36% | UBS | $38 → $36 | Maintains | Neutral | |||
09/16/2024 | -18.02% | Mizuho | $45 → $43 | Maintains | Neutral | |||
09/13/2024 | -14.2% | Morgan Stanley | $45 → $45 | Maintains | Overweight | |||
09/12/2024 | -29.46% | JP Morgan | $42 → $37 | Maintains | Overweight | |||
08/23/2024 | -29.46% | Citigroup | → $37 | Reinstates | → Neutral | |||
08/15/2024 | -38.99% | Piper Sandler | $43 → $32 | Downgrade | Overweight → Neutral | |||
08/14/2024 | -19.92% | Wells Fargo | $40 → $42 | Upgrade | Equal-Weight → Overweight | |||
07/25/2024 | -18.02% | Piper Sandler | $47 → $43 | Maintains | Overweight | |||
07/24/2024 | -12.3% | Stephens & Co. | $47 → $46 | Maintains | Equal-Weight | |||
07/23/2024 | -19.92% | JP Morgan | → $42 | Upgrade | Neutral → Overweight | |||
07/22/2024 | -38.99% | Truist Securities | $36 → $32 | Maintains | Hold | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Outperform | |||
07/18/2024 | -10.39% | Piper Sandler | $46 → $47 | Maintains | Overweight | |||
07/12/2024 | 4.86% | Scotiabank | $54 → $55 | Maintains | Sector Outperform | |||
06/04/2024 | -8.48% | Jefferies | $43 → $48 | Maintains | Buy | |||
05/13/2024 | -14.2% | Mizuho | $43 → $45 | Maintains | Neutral | |||
05/13/2024 | -10.39% | BMO Capital | $40 → $47 | Maintains | Outperform | |||
05/09/2024 | 2.96% | Scotiabank | $52 → $54 | Maintains | Sector Outperform | |||
04/30/2024 | -12.3% | Piper Sandler | $41 → $46 | Reiterates | Overweight → Overweight | |||
04/26/2024 | -18.02% | Mizuho | $40 → $43 | Maintains | Neutral | |||
04/24/2024 | -10.39% | Stephens & Co. | $46 → $47 | Maintains | Equal-Weight | |||
04/19/2024 | -21.83% | Piper Sandler | $47 → $41 | Maintains | Overweight | |||
04/19/2024 | -18.02% | TD Cowen | → $43 | Reinstates | → Hold | |||
04/17/2024 | -6.58% | Morgan Stanley | $37 → $49 | Maintains | Overweight | |||
04/17/2024 | -29.46% | Wells Fargo | $48 → $37 | Downgrade | Overweight → Equal-Weight | |||
04/16/2024 | -23.74% | Mizuho | $39 → $40 | Maintains | Neutral | |||
04/11/2024 | -0.86% | Scotiabank | $40 → $52 | Upgrade | Sector Perform → Sector Outperform | |||
04/10/2024 | -35.18% | Bernstein | $27 → $34 | Upgrade | Underperform → Market Perform | |||
04/05/2024 | -33.27% | Truist Securities | $37 → $35 | Maintains | Hold | |||
04/05/2024 | -18.02% | Jefferies | $42 → $43 | Maintains | Buy | |||
04/04/2024 | -25.64% | Mizuho | → $39 | Reiterates | Neutral → Neutral |
FAQ
Quel est le cours indicatif de l'action EQT (EQT) ?
Le dernier objectif de prix pour EQT (NYSE:EQT) a été rapporté par Wells Fargo le octobre 23, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $66.00 s'attendant à ce que EQT se rise dans les 12 prochains mois (un possible changement de 25.83% upside). 64 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour EQT (EQT) ?
La dernière note d'analyste pour EQT (NYSE:EQT) a été fournie par Wells Fargo, et EQT maintenu leur note overweight.
Quand a eu lieu la dernière mise à niveau pour EQT (EQT) ?
La dernière amélioration pour EQT Corp a eu lieu le mai 5, 2025 lorsque UBS a augmenté leur objectif de prix à $64. UBS avait précédemment a neutral pour EQT Corp.
Quand a eu lieu la dernière dégradation pour EQT (EQT) ?
La dernière réduction pour EQT Corp a eu lieu le août 18, 2025 lorsque Roth Capital a changé leur objectif de prix de $75 à $57 pour EQT Corp.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour EQT (EQT) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de EQT, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour EQT a été déposée le octobre 23, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 23, 2026.
La note d'analyste pour EQT (EQT) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de EQT (EQT) était un maintenu avec un objectif de prix de $68.00 à $66.00. Le prix actuel de EQT (EQT) est de $52.45, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.